Table 20.
2016 Estimated New Cases | 2017 Estimated New Cases | |||||||
---|---|---|---|---|---|---|---|---|
Histology | 0-14 | 15-39 | 40-64 | 65+ | 0-14 | 15-39 | 40-64 | 65+ |
Tumors of Neuroepithelial Tissue | 3,140 | 3,480 | 8,690 | 8,040 | 3,160 | 3,480 | 8,760 | 8,260 |
Pilocytic astrocytoma | 790 | 300 | 90 | -- | 810 | 300 | 90 | -- |
Diffuse astrocytoma | 190 | 390 | 490 | 320 | 180 | 380 | 470 | 310 |
Anaplastic astrocytoma | 90 | 340 | 620 | 590 | 90 | 350 | 630 | 660 |
Unique astrocytoma variants | 90 | 80 | -- | -- | 90 | 80 | -- | -- |
Glioblastoma | 170 | 510 | 5,390 | 6,120 | 180 | 520 | 5,470 | 6,270 |
Oligodendroglioma | -- | 250 | 320 | 70 | -- | 240 | 310 | 70 |
Anaplastic oligodendroglioma | -- | 80 | 200 | 60 | -- | 70 | 200 | 60 |
Oligoastrocytic tumors | -- | 280 | 250 | 70 | -- | 290 | 250 | 70 |
Ependymal tumors | 250 | 360 | 590 | 240 | 250 | 360 | 590 | 250 |
Glioma malignant, NOS | 570 | 300 | 320 | 370 | 570 | 310 | 330 | 370 |
Choroid plexus tumors | 70 | 70 | -- | -- | 70 | 80 | -- | -- |
Other neuroepithelial tumors | -- | -- | -- | -- | -- | -- | -- | -- |
Neuronal and mixed neuronal- glial tumors | 360 | 300 | 240 | 80 | 360 | 290 | 240 | 80 |
Tumors of the pineal region | -- | 60 | 60 | -- | -- | 60 | 60 | -- |
Embryonal tumors | 460 | 160 | -- | -- | 450 | 160 | -- | -- |
Tumors of Cranial and Spinal Nerves | 210 | 960 | 3,470 | 1,950 | 200 | 970 | 3,510 | 2,010 |
Nerve sheath tumors | 210 | 960 | 3,470 | 1,940 | 200 | 960 | 3,500 | 2,000 |
Other tumors of cranial and spinal nerves | -- | -- | -- | -- | -- | -- | -- | -- |
Tumors of Meninges | 240 | 2,030 | 11,240 | 16,240 | 250 | 2,050 | 11,200 | 16,680 |
Meningioma | 140 | 1,770 | 10,830 | 16,070 | 150 | 1,790 | 10,790 | 16,500 |
Mesenchymal tumors | 60 | 70 | 110 | 50 | 60 | 70 | 110 | 50 |
Primary melanocytic lesions | -- | -- | -- | -- | -- | -- | -- | -- |
Other neoplasms related to the meninges | -- | 190 | 270 | 120 | 50 | 190 | 270 | 120 |
Lymphomas and Hematopoietic Neoplasms | -- | 100 | 560 | 840 | -- | 90 | 560 | 850 |
Lymphoma | -- | 80 | 540 | 820 | -- | 80 | 540 | 830 |
Other hematopoietic neoplasms | -- | -- | -- | -- | -- | -- | -- | -- |
Germ Cell Tumors and Cysts | 190 | 110 | -- | -- | 190 | 100 | -- | -- |
Germ cell tumors, cysts and heterotopias | 190 | 110 | -- | -- | 190 | 100 | -- | -- |
Tumors of Sellar Region | 800 | 3,930 | 6,390 | 3,750 | 820 | 4,030 | 6,610 | 3,910 |
Tumors of the pituitary | 640 | 3,800 | 6,170 | 3,630 | 660 | 3,900 | 6,390 | 3,780 |
Craniopharyngioma | 160 | 130 | 220 | 120 | 160 | 130 | 220 | 120 |
Unclassified Tumors | 350 | 600 | 1,230 | 2,060 | 370 | 580 | 1,210 | 2,120 |
Hemangioma | 150 | 280 | 430 | 490 | 170 | 270 | 400 | 560 |
Neoplasm, unspecified | 180 | 310 | 790 | 1,560 | 190 | 310 | 800 | 1,550 |
All other | -- | -- | -- | -- | -- | -- | -- | -- |
TOTAL‡ | 4,770 | 11,110 | 31,590 | 32,870 | 4,830 | 11,200 | 31,850 | 33,820 |
aSource: Estimation based on CBTRUS NPCR and SEER 2006-2013 data.
bRounded to the nearest 10. Numbers may not add up due to rounding.
– Estimated number is less than 50 and may affect totals.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology and End Results program; CI, confidence interval; NOS, not otherwise specified.